Haemonetics Corporation Earnings

The next earnings date for Haemonetics Corporation is February 4, 2026.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of Haemonetics Corporation Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Haemonetics Corporation Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/06/2025Before Market------
08/07/2025---$1.107.84%
05/08/2025Before Market$1.241.61%
02/06/2025Before Market$1.191.66%
11/07/2024Before Market$1.124.67%
08/08/2024Before Market$1.020.99%
05/09/2024Before Market$0.901.12%
02/08/2024Before Market$1.0410.64%
11/02/2023Before Market$0.9911.24%
08/08/2023Before Market$1.0543.84%
05/11/2023Before Market$0.7710.00%
02/07/2023Before Market$0.856.25%
11/07/2022Before Market$0.8323.88%
08/10/2022Before Market$0.5813.73%
05/10/2022Before Market$0.658.33%
02/08/2022Before Market$0.8415.07%
11/09/2021Before Market$0.60-1.64%
08/11/2021Before Market$0.5011.11%
05/13/2021Before Market$0.46-31.34%
02/02/2021Before Market$0.8124.62%
11/04/2020Before Market$0.6221.57%
08/04/2020Before Market$0.4612.20%
05/05/2020Before Market$0.69-5.48%
02/04/2020Before Market$0.9423.68%
11/01/2019Before Market$0.8726.09%
08/06/2019Before Market$0.8128.57%
05/07/2019Before Market$0.6110.91%
02/05/2019Before Market$0.636.78%
11/06/2018Before Market$0.563.70%
08/07/2018Before Market$0.5940.48%
05/08/2018Before Market$0.432.38%
02/06/2018Before Market$0.6240.91%
11/07/2017Before Market$0.4817.07%
08/07/2017Before Market$0.336.45%
05/08/2017Before Market$0.392.63%
02/06/2017Before Market$0.434.88%
11/07/2016Before Market$0.4631.43%
08/01/2016Before Market$0.25-10.71%
05/02/2016Before Market$0.37-19.57%
02/01/2016Before Market$0.484.35%
11/04/2015Before Market$0.4412.82%
07/27/2015Before Market$0.359.38%
04/27/2015Before Market$0.47-9.62%
01/29/2015Before Market$0.533.92%
11/03/2014Before Market$0.472.17%
07/30/2014---$0.385.56%
04/28/2014---$0.46-20.69%
01/27/2014---$0.611.67%
10/28/2013---$0.6613.79%
07/29/2013---$0.46-2.13%
05/01/2013---$0.484.35%
01/30/2013---$0.506.38%
10/29/2012---$0.4518.42%
08/01/2012---$0.28-22.22%
04/30/2012---$0.40-4.76%
01/30/2012---$0.437.50%
10/31/2011---$0.36-5.26%
08/01/2011---$0.33-15.38%
05/02/2011---$0.434.88%
01/31/2011---$0.459.76%
11/01/2010---$0.405.26%
08/02/2010---$0.372.78%
05/04/2010---$0.380.00%
02/01/2010---$0.360.00%
11/02/2009---$0.359.38%
08/03/2009---$0.356.06%
05/04/2009---$0.336.45%
02/02/2009---$0.326.67%
10/27/2008---$0.2911.54%
08/01/2008---$0.3011.11%
05/01/2008---$0.290.00%
01/31/2008---$0.283.70%
11/01/2007---$0.230.00%
08/02/2007---$0.250.00%
05/02/2007---$0.3313.79%
01/31/2007---$0.2812.00%
10/31/2006---$0.23-4.17%
07/27/2006---$0.26-7.14%
05/03/2006---$0.3110.71%
01/31/2006---$0.258.70%
10/27/2005---$0.205.26%
07/28/2005---$0.2426.32%
05/05/2005---$0.195.56%
01/31/2005---$0.2116.67%
11/01/2004---$0.170.00%
07/29/2004---$0.1911.76%
05/03/2004---$0.1911.76%
01/22/2004---$0.1911.76%
10/23/2003---$0.1515.38%
07/24/2003---$0.1110.00%
04/24/2003---$0.09-25.00%
01/23/2003---$0.2116.67%
10/24/2002---$0.147.69%
07/25/2002---$0.130.00%
05/02/2002---$0.14-6.67%
01/24/2002---$0.185.88%
10/25/2001---$0.1926.67%
07/26/2001---$0.1926.67%
05/03/2001---$0.140.00%
01/25/2001---$0.1713.33%
10/26/2000---$0.130.00%
07/27/2000---$0.130.00%
05/04/2000---$0.140.00%
01/27/2000---$0.130.00%
10/28/1999---$0.1110.00%
07/29/1999---$0.1122.22%
05/06/1999---$0.1233.33%
01/29/1999---$0.09-10.00%
10/26/1998---$0.1025.00%
07/27/1998---$0.1025.00%
05/04/1998---$-0.06-154.55%
01/27/1998Before Market$0.09-18.18%
10/16/1997Before Market$0.08-27.27%
04/15/1997Before Market$0.147.69%
01/14/1997Before Market$0.130.00%
10/11/1996---$0.16-5.88%
07/15/1996---$0.176.25%
04/18/1996---$0.170.00%
01/15/1996---$0.160.00%
10/15/1995---$0.176.25%
07/16/1995---$0.160.00%

More About Haemonetics Corporation

Country
USA
Full Time Employees
3,023

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE closure products comprising VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, clinical specialists, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Haemonetics Corporation Earnings” Can Refer to the Haemonetics Corporation Earnings Date

Some people say “Haemonetics Corporation earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Haemonetics Corporation position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Haemonetics Corporation Stock on the Earnings Date

If you own Haemonetics Corporation stock (HAE) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Haemonetics Corporation might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Haemonetics Corporation shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Haemonetics Corporation Earnings

You can contact us any time if you would like to ask questions about Haemonetics Corporation earnings or anything else related to the stock market.